Kimbo Chia
Surgery · Buffalo, NYNPI 1326159237
Payments from drug & device makers
Across 87 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$261
- Misonix Inc$259
- Integra Lifesciences Corporation$166
- Acera Surgical, Inc.$161
- Polynovo North America LLC$158
- Medela LLC$131
- plus $684 from 13 others
What the payments were for
- Food & beverage$1,820100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 15 | $261 |
| Misonix Inc | 15 | $259 |
| Integra Lifesciences Corporation | 7 | $166 |
| Acera Surgical, Inc. | 8 | $161 |
| Polynovo North America LLC | 7 | $158 |
| Medela LLC | 4 | $131 |
| Orexo US, Inc. | 5 | $109 |
| Organogenesis Inc. | 6 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $81 |
| Solventum Corporation | 1 | $70 |
| Vertex | 2 | $61 |
| Sanara Medtech Inc. | 3 | $59 |
| AbbVie(2 entities) | 3 | $51 |
| Kerecis Limited | 2 | $37 |
| Aroa Biosurgery Incorporated | 2 | $34 |
| Avita Medical Americas, LLC | 1 | $32 |
| Shire North American Group Inc | 1 | $24 |
| Acell, Inc. | 1 | $18 |
| Polymedics Innovations Inc. | 1 | $16 |
How this compares
$1,820 in reported general payments places this provider in the 55th percentile of 1,596 surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 108 | $12,766 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $3,189 |
| Clindamycin Phosphate | 22 | $1,531 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 75 | $943 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 25 | $672 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 19 | $669 |
| Pantoprazole Sodium | 16 | $523 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $508 |
| Ibuprofen | 49 | $396 |
| Cephalexin | 25 | $394 |
| Zolpidem Tartrate | 25 | $171 |
| Carisoprodol | 35 | $167 |
| Tramadol Hcl | 25 | $154 |
| Baclofen | 12 | $133 |
| Gabapentin | 12 | $73 |
Paid to pharmacies, not to this prescriber.
Other surgery in Buffalo
- Thom LoreeBuffalo$1M
- Vinod BalachandranNew York$3M
- Stephanie GoffNew York$2.7M
- Alice WeiNew York$2.3M
- Cheguevara AfanehNew York$1.4M
- Ajay PanchalAmherst$893K
- Flavio Malcher Martins de OliveiraNew York$814K
- Bonnie LonzeNew York$650K
- Stephen GoldstoneNy$647K
- Yuri NovitskyNew York$548K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.